About this episode
Stocks surged for a second straight day, with the major indices now more than 5% above their 2022 lows, and Jim Cramer is taking a closer look at what drove the averages higher. First, Biohaven closed its deal with Pfizer yesterday, selling its CGRP franchise to Pfizer for $11.6b, and Cramer is talking to Biohaven CEO Vlad Coric about the transaction and its pipeline of bipolar disorder and epilepsy treatments. Then, after a massive two-day rally, could this market rally keep running or is it due to run out of steam? Cramer's going Off The Charts to find out. Plus, Cramer's exclusive with Suntory Holdings CEO Tak Niinami. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.